The South African Health Products Regulatory Authority has approved Oramed Pharmaceuticals to begin clinical testing of an oral vaccine against Covid-19. The company, which is listed in the US, has been granted permission to enroll patients in Phase 1 trials.
–>
+ Pfizer starts drug trials against Covid-19 in Brazil
According to a company statement, the format of the vaccine would help overcome some of the logistical obstacles in Africa, such as the need to refrigerate doses. The vaccine uses “virus-like particle” to target three proteins on the surface of the coronavirus, including those less susceptible to mutation.
Also according to the company, this feature could make the vaccine more effective in the future against variants of the virus. For the company’s CEO, Nadav Kidron, the oral form “would eliminate several barriers to rapid and large-scale distribution, potentially allowing people to take the vaccine on their own at home.”
See too
+ How podcasts can help Brazilians’ financial education
+ Mystery: woman discovers that she is not the biological mother of her own children
+ Lemon-squeezing trick becomes a craze on social media
+ Chef playmate creates aphrodisiac recipe for Orgasm Day
+ Mercedes-Benz Sprinter wins motorhome version
+ Anorexia, an eating disorder that can lead to death
+ US agency warns: never wash raw chicken meat
+ Yasmin Brunet breaks the silence
+ Shark is captured in MA with the remains of youngsters missing in the stomach
+ See how much it costs to eat at the MasterChef judges’ restaurants
+ Auction of cars and motorcycles from Kombi to Nissan Frontier 0km
#Covid19 #Pharmacist #Begins #Oral #Vaccine #Trials #South #Africa